Filing Flows › Si-Bone (SIBN) › Q2 2026 › vs Q1 2026
Si-Bone (SIBN) Q2 2026 vs Q1 2026 (quarter over quarter)
Si-Bone's revenue rose $3.4M (+7%) from $52.6M in Q1 2026 to $56.0M in Q2 2026.
Si-Bone, Q2 2026: revenue $56.0M (+15% year over year), operating margin -8.6%, net loss $4.1M, operating cash flow $777K. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $56.0M | $52.6M | $3.4M | +7% |
| Other income, net | $718K | $759K | −$41K | -5% |
| Net loss | $4.1M | $4.3M | −$246K | -6% |
| Costs & expenses | $60.8M | $57.7M | $3.1M | +5% |
| Operating costs | $60.8M | $57.7M | $3.1M | +5% |
| Cost of revenue | $11.5M | $10.6M | $818K | +8% |
| Research & development | $5.2M | $4.2M | $1.0M | +25% |
| Sales & marketing | $34.0M | $32.8M | $1.2M | +4% |
| General & admin | $10.1M | $10.0M | $72K | +0.7% |
| Operating cash sources | $7.7M | $7.6M | $16K | +0.2% |
| Depreciation & amortization | $1.7M | $1.6M | $62K | +4% |
| Share-based compensation | $6.0M | $6.0M | −$46K | -0.8% |
| Net loss absorbed | $4.1M | $4.3M | −$246K | -6% |
| Working capital & other | $2.8M | $5.7M | −$2.9M | -51% |
| Operating cash flow | $777K | −$2.4M | $3.1M | — |
| Capital expenditures | $1.5M | $1.1M | $468K | +43% |
| Negative free cash flow (OCF − capex) | $768K | $3.4M | −$2.7M | -78% |
Questions
How much did Si-Bone's revenue grow quarter over quarter in Q2 2026?
Si-Bone's revenue rose $3.4M (+7%) from $52.6M in Q1 2026 to $56.0M in Q2 2026.